Liabilities / Assets
52nd percentile
Tied with the lowest-debt nonprofits in its peer group.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
53rd percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
98th percentile
Higher net margin than 98% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
75th percentile
Faster asset growth than 75% of similar nonprofits.
Revenue Growth
84th percentile
Faster revenue growth than 84% of similar nonprofits.
Balance Sheet
Assets
Up$114,174
Up $29,449 (+35%) from 2019
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
$0
No earlier filing loaded for comparison.
Revenue And Expenses
Revenue
Up$31,074
Up $7,284 (+31%) from 2019
Expenses
Up$1,625
Up $700 (+76%) from 2019
Net Income
Up$29,449
Up $6,584 (+29%) from 2019
Historical Trend
Filing Detail Status
This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2020 to Dec 31, 2020
Mission and Program Overview
Mission
To further by clinical study, laboratory research, publication and teaching the knowledge of chronic disease of the eye and the application of such knowledge for the benefit of the public at large on a nondiscriminatory basis, to the prevention and treatment of eye diseases, in particular diabetic retinopathy, macular degeneration and vascular occlusive disease that affect the retina
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2020 • Form 990EZSummary only. Only limited summary data is available for this year.
- Assets
- $114,174
- Liabilities
- $0
- Net assets
- -
- Revenue
- $31,074
- Expenses
- $1,625
- Net income
- $29,449